Drug companies using tax windfall to benefit shareholders, not patients

If only the shareholders from drug companies are getting the benefit of tax savings and not the general public, then how do families pay for their medications?  What are your thoughts? Please add your comments below.

Drug companies using tax windfall to benefit shareholders, not patients   From The Office of U.S. Senator Cory A. Booker, April 9, 2018

Be the first to comment

Please check your e-mail for a link to activate your account.